Chronic Lung Disease of Prematurity Completed Phase 3 Trials for Nitric Oxide (DB00435)

Also known as: Bronchopulmonary Dysplasia / Ventilator lung in newborn / Congenital pulmonary fibrosis

IndicationStatusPhase
DBCOND0044076 (Chronic Lung Disease of Prematurity)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00931632Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm InfantsTreatment
NCT00006401Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature InfantsPrevention